CMA launches formal investigation into COVID-19 PCR test firm
Expert Medicals – one of the largest PCR travel test providers in the UK this summer – has received a ‘high number of complaints’
Read More
Tag: CMA
Pfizer, Flynn accused of charging the NHS ‘unfairly high prices’ for anti-epilepsy drug
UK Competition and Markets Authority provisionally finds drug companies broke competition law
Read More
CMA fines Advanz over ‘excessive and unfair’ pricing of thyroid drug
The £100m fine sends ‘a clear message’ to the pharma sector, said the CMA
Read More
CMA imposes substantial fines on pharma firms for overcharging the NHS
Competition regulator announces fines totalling £260m relating to the supply of hydrocortisone tablets
Read More
AZ scores final clearance for Alexion acquisition in the UK
UK approval of the acquisition comes just a week after the merger scored clearance in the EU
Read More
Tribunal upholds CMA’s decision to fine Lexon £1.2m
Company found to have broken competition law to drive up prices of antidepressant nortriptyline
Read More
CMA levies fines of £2.3m in pharma probe
The fines are in addition to £8 million secured for the NHS last year as part of the case
Read More
CMA imposes £1.2m fines for price-fixing in private eye care
Consultant ophthalmologists at Spire hospital conspired to fix prices for private consultations
Read More
COVID-19: CMA, NIHR, AbbVie updates
The current recorded case count for COVID-19 (coronavirus) in the UK has hit 3,269, with 144 deaths and 65 recoveries.
Read More
GSK hit with EU Court ruling over ‘pay-for-delay’ drug case
The ruling harks back to the CMA’s 2016 case that found GlaxoSmithKline had agreed to make payments totalling over £50 million to other generic suppliers of paroxetine.
Read More
UK green light for Roche’s purchase of Spark
The Competition and Markets Authority has unconditionally approved the deal
Read More
Advanz, Morningside, Alliance accused of illegal market sharing
The CMA alleges that Alliance Healthcare bought equal volumes of nitrofurantoin from the companies to discourage competing.
Read More
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
- Johnson & Johnson seeks EMA approval for teclistamab–daratumumab combination
- HUTCHMED begins phase 3 stage of pancreatic cancer trial
- Zenas reports strong phase 3 results for obexelimab in IgG4-related disease
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
